Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Glynne-Jones

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 25, 2010
Are we ready to use an early alternative end point as the primary end point of a phase III study in rectal cancer?Rob Glynne-Jones, David Sebag-Montefiore
Cancer Treatment Reviews|January 31, 2020
How to measure tumour response in rectal cancer? An explanation of discrepancies and suggestions for improvementIris D Nagtegaal, Rob Glynne-Jones
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Is the NSABP R-03 study in line with other chemoradiation studies?Rob Glynne-Jones, Mark Harrison, Robert Hughes
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
The Management and Prevention of Anal Squamous Cell CarcinomaCathy Eng, Craig Messick, Rob Glynne-Jones
Current Oncology Reports|February 2, 2013
Anal cancer: are we making progress?Ajay Aggarwal, Simon Duke, Rob Glynne-Jones
Journal of Gastrointestinal Oncology|September 3, 2013
The status of targeted agents in the setting of neoadjuvant radiation therapy in locally advanced rectal cancersRob Glynne-Jones, Maher Hadaki, Mark Harrison
Acta Oncologica (Stockholm, Sweden)|February 26, 2010
Cetuximab and chemoradiation for rectal cancer--is the water getting muddy?Rob Glynne-Jones, Suzy Mawdsley, Mark Harrison
Diseases of the Colon and Rectum|May 7, 2015
The D prefix: toward a reproducible validated alternative end point in rectal cancerRob Glynne-Jones, Nicholas P West, Philip Quirke
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Multimodal Rectal Cancer Treatment: In Some Cases, Less May Be MoreJulio Garcia-Aguilar, Rob Glynne-Jones, Deborah Schrag
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2012
Capturing data on colostomy formation in anal cancerRob Glynne-Jones, Sandy Beare, Rubina Begum, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 25, 2010
Are we ready to use an early alternative end point as the primary end point of a phase III study in rectal cancer?Rob Glynne-Jones, David Sebag-Montefiore
Cancer Treatment Reviews|January 31, 2020
How to measure tumour response in rectal cancer? An explanation of discrepancies and suggestions for improvementIris D Nagtegaal, Rob Glynne-Jones
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Is the NSABP R-03 study in line with other chemoradiation studies?Rob Glynne-Jones, Mark Harrison, Robert Hughes
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
The Management and Prevention of Anal Squamous Cell CarcinomaCathy Eng, Craig Messick, Rob Glynne-Jones
Current Oncology Reports|February 2, 2013
Anal cancer: are we making progress?Ajay Aggarwal, Simon Duke, Rob Glynne-Jones
Journal of Gastrointestinal Oncology|September 3, 2013
The status of targeted agents in the setting of neoadjuvant radiation therapy in locally advanced rectal cancersRob Glynne-Jones, Maher Hadaki, Mark Harrison
Acta Oncologica (Stockholm, Sweden)|February 26, 2010
Cetuximab and chemoradiation for rectal cancer--is the water getting muddy?Rob Glynne-Jones, Suzy Mawdsley, Mark Harrison
Diseases of the Colon and Rectum|May 7, 2015
The D prefix: toward a reproducible validated alternative end point in rectal cancerRob Glynne-Jones, Nicholas P West, Philip Quirke
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Multimodal Rectal Cancer Treatment: In Some Cases, Less May Be MoreJulio Garcia-Aguilar, Rob Glynne-Jones, Deborah Schrag
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2012
Capturing data on colostomy formation in anal cancerRob Glynne-Jones, Sandy Beare, Rubina Begum, et al.
Pageof 9